(Q43040891)

12 November 2017

title

Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia (English)

1 reference

12 November 2017

0 references

F Mouaffak

1

1 reference

12 November 2017

O Kebir

2

1 reference

12 November 2017

M Chayet

3

1 reference

12 November 2017

S Tordjman

4

1 reference

12 November 2017

M N Vacheron

5

1 reference

12 November 2017

B Millet

6

1 reference

12 November 2017

N Jaafari

7

1 reference

12 November 2017

A Bellon

8

1 reference

12 November 2017

J P Olié

9

1 reference

12 November 2017

M-O Krebs

10

1 reference

12 November 2017

publication date

8 June 2010

1 reference

The Pharmacogenomics Journal

12 November 2017

published in

1 reference

12 November 2017

volume

11

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

267-273

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2010.40

12 November 2017

exact match

0 references

cites work

Management of treatment resistance in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Clozapine eligibility among state hospital patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Antipsychotic drugs: clinical pharmacology and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Suicidal risk during treatment with clozapine: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

When symptoms persist: clozapine augmentation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Evolutionary constraints on the Disrupted in Schizophrenia locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

The DISC locus in psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Modeling cognitive endophenotypes of schizophrenia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Disruption of two novel genes by a translocation co-segregating with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Positive association of the Disrupted-in-Schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Association study of polymorphisms between DISC1 and schizophrenia in a Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Does the addition of a second antipsychotic drug improve clozapine treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Behavioral phenotypes of Disc1 missense mutations in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

Tubulin synthesis and assembly in differentiating neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

The neuropathological effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.40

21 January 2018

Identifiers

DOI

10.1038/TPJ.2010.40

1 reference

Dimensions Publication ID

12 November 2017

1045253959

0 references

1 reference